111's total revenue is $8.8B, below the Healthcare sector average of $110B.
Get informed when a big investor buys or sells
+ FollowAs of Mar 2026
Trailing 12 months ending Mar 2026
As of the most recent data (March 2026), YI shows a total revenue of $8.8B. That compares with $14B in the prior-year period — down 39.1% year over year. That is below the Healthcare sector average of $110B. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, YI's total revenue is now $8.8B (was $14B) — a 39.1% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether 111 is outperforming or lagging.
The Healthcare sector average total revenue is about $110B. 111 is at $8.8B, which is lower that average. That is roughly 91.9% below the sector mean. Use the comparison chart on this page to see how YI stacks up against individual peers as well.
Tracking YI's total revenue over time shows whether 111 is scaling, shrinking, or reshaping that part of the business. The current reading is $8.8B That compares with $14B in the prior-year period — down 39.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this total revenue page, Stockcircle has 111's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total revenue (currently $8.8B) with ownership activity and broader fundamentals.